Report Detail

Request for Sample of this report

Pharma & Healthcare Global Human Bloodm Albumin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4734144
    • |
  • 24 August, 2026
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Bloodm Albumin market size was valued at US$ 6923 million in 2025 and is forecast to a readjusted size of US$ 10600 million by 2032 with a CAGR of 6.3% during review period.
Human blood albumin is a plasma protein produced by the liver that plays a crucial role in maintaining oncotic pressure, transporting hormones, fatty acids, and other substances, and regulating blood volume. It is commonly used in medical treatments for conditions such as hypovolemia, burns, shock, and hypoalbuminemia. Human blood albumin is derived from donated human plasma and is purified for therapeutic use in hospitals and medical facilities. Due to its essential function in stabilizing blood circulation, it is widely used in critical care and surgical procedures.
The Human Bloodm Albumin market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, Human Bloodm Albumin is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.
However, the market faces challenges such as limited plasma supply and high production costs, as Human Bloodm Albumin is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant Human Bloodm Albumin is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global Human Bloodm Albumin market.
The key global producers of Human Bloodm Albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.
This report is a detailed and comprehensive analysis for global Human Bloodm Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Bloodm Albumin market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2021-2032
Global Human Bloodm Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2021-2032
Global Human Bloodm Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2021-2032
Global Human Bloodm Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/Kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Bloodm Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Bloodm Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Bloodm Albumin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20-25% Concentrations
5% Concentrations
Market segment by Application
Therapeutics
Excipient
Other
Major players covered
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Weiguang Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Bloodm Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Bloodm Albumin, with price, sales quantity, revenue, and global market share of Human Bloodm Albumin from 2021 to 2026.
Chapter 3, the Human Bloodm Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Bloodm Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Bloodm Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Bloodm Albumin.
Chapter 14 and 15, to describe Human Bloodm Albumin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Bloodm Albumin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 20-25% Concentrations
    • 1.3.3 5% Concentrations
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Bloodm Albumin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Therapeutics
    • 1.4.3 Excipient
    • 1.4.4 Other
  • 1.5 Global Human Bloodm Albumin Market Size & Forecast
    • 1.5.1 Global Human Bloodm Albumin Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Human Bloodm Albumin Sales Quantity (2021-2032)
    • 1.5.3 Global Human Bloodm Albumin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Grifols
    • 2.1.1 Grifols Details
    • 2.1.2 Grifols Major Business
    • 2.1.3 Grifols Human Bloodm Albumin Product and Services
    • 2.1.4 Grifols Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Grifols Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Human Bloodm Albumin Product and Services
    • 2.2.4 CSL Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 Takeda
    • 2.3.1 Takeda Details
    • 2.3.2 Takeda Major Business
    • 2.3.3 Takeda Human Bloodm Albumin Product and Services
    • 2.3.4 Takeda Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Takeda Recent Developments/Updates
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Human Bloodm Albumin Product and Services
    • 2.4.4 Octapharma Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Octapharma Recent Developments/Updates
  • 2.5 CBPO
    • 2.5.1 CBPO Details
    • 2.5.2 CBPO Major Business
    • 2.5.3 CBPO Human Bloodm Albumin Product and Services
    • 2.5.4 CBPO Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CBPO Recent Developments/Updates
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Human Bloodm Albumin Product and Services
    • 2.6.4 Hualan Bio Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hualan Bio Recent Developments/Updates
  • 2.7 Kedrion
    • 2.7.1 Kedrion Details
    • 2.7.2 Kedrion Major Business
    • 2.7.3 Kedrion Human Bloodm Albumin Product and Services
    • 2.7.4 Kedrion Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Kedrion Recent Developments/Updates
  • 2.8 Shanghai RAAS
    • 2.8.1 Shanghai RAAS Details
    • 2.8.2 Shanghai RAAS Major Business
    • 2.8.3 Shanghai RAAS Human Bloodm Albumin Product and Services
    • 2.8.4 Shanghai RAAS Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shanghai RAAS Recent Developments/Updates
  • 2.9 LFB Group
    • 2.9.1 LFB Group Details
    • 2.9.2 LFB Group Major Business
    • 2.9.3 LFB Group Human Bloodm Albumin Product and Services
    • 2.9.4 LFB Group Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 LFB Group Recent Developments/Updates
  • 2.10 Weiguang Bio
    • 2.10.1 Weiguang Bio Details
    • 2.10.2 Weiguang Bio Major Business
    • 2.10.3 Weiguang Bio Human Bloodm Albumin Product and Services
    • 2.10.4 Weiguang Bio Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Weiguang Bio Recent Developments/Updates
  • 2.11 Tiantan Bio
    • 2.11.1 Tiantan Bio Details
    • 2.11.2 Tiantan Bio Major Business
    • 2.11.3 Tiantan Bio Human Bloodm Albumin Product and Services
    • 2.11.4 Tiantan Bio Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Tiantan Bio Recent Developments/Updates
  • 2.12 Shuanglin Bio
    • 2.12.1 Shuanglin Bio Details
    • 2.12.2 Shuanglin Bio Major Business
    • 2.12.3 Shuanglin Bio Human Bloodm Albumin Product and Services
    • 2.12.4 Shuanglin Bio Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shuanglin Bio Recent Developments/Updates
  • 2.13 Boya Bio
    • 2.13.1 Boya Bio Details
    • 2.13.2 Boya Bio Major Business
    • 2.13.3 Boya Bio Human Bloodm Albumin Product and Services
    • 2.13.4 Boya Bio Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Boya Bio Recent Developments/Updates
  • 2.14 Yuanda Shuyang
    • 2.14.1 Yuanda Shuyang Details
    • 2.14.2 Yuanda Shuyang Major Business
    • 2.14.3 Yuanda Shuyang Human Bloodm Albumin Product and Services
    • 2.14.4 Yuanda Shuyang Human Bloodm Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Yuanda Shuyang Recent Developments/Updates

3 Competitive Environment: Human Bloodm Albumin by Manufacturer

  • 3.1 Global Human Bloodm Albumin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human Bloodm Albumin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human Bloodm Albumin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human Bloodm Albumin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human Bloodm Albumin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human Bloodm Albumin Manufacturer Market Share in 2025
  • 3.5 Human Bloodm Albumin Market: Overall Company Footprint Analysis
    • 3.5.1 Human Bloodm Albumin Market: Region Footprint
    • 3.5.2 Human Bloodm Albumin Market: Company Product Type Footprint
    • 3.5.3 Human Bloodm Albumin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Bloodm Albumin Market Size by Region
    • 4.1.1 Global Human Bloodm Albumin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human Bloodm Albumin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human Bloodm Albumin Average Price by Region (2021-2032)
  • 4.2 North America Human Bloodm Albumin Consumption Value (2021-2032)
  • 4.3 Europe Human Bloodm Albumin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human Bloodm Albumin Consumption Value (2021-2032)
  • 4.5 South America Human Bloodm Albumin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human Bloodm Albumin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human Bloodm Albumin Sales Quantity by Type (2021-2032)
  • 5.2 Global Human Bloodm Albumin Consumption Value by Type (2021-2032)
  • 5.3 Global Human Bloodm Albumin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human Bloodm Albumin Sales Quantity by Application (2021-2032)
  • 6.2 Global Human Bloodm Albumin Consumption Value by Application (2021-2032)
  • 6.3 Global Human Bloodm Albumin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human Bloodm Albumin Sales Quantity by Type (2021-2032)
  • 7.2 North America Human Bloodm Albumin Sales Quantity by Application (2021-2032)
  • 7.3 North America Human Bloodm Albumin Market Size by Country
    • 7.3.1 North America Human Bloodm Albumin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human Bloodm Albumin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human Bloodm Albumin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human Bloodm Albumin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human Bloodm Albumin Market Size by Country
    • 8.3.1 Europe Human Bloodm Albumin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human Bloodm Albumin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Bloodm Albumin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human Bloodm Albumin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human Bloodm Albumin Market Size by Region
    • 9.3.1 Asia-Pacific Human Bloodm Albumin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human Bloodm Albumin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human Bloodm Albumin Sales Quantity by Type (2021-2032)
  • 10.2 South America Human Bloodm Albumin Sales Quantity by Application (2021-2032)
  • 10.3 South America Human Bloodm Albumin Market Size by Country
    • 10.3.1 South America Human Bloodm Albumin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human Bloodm Albumin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Bloodm Albumin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human Bloodm Albumin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human Bloodm Albumin Market Size by Country
    • 11.3.1 Middle East & Africa Human Bloodm Albumin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human Bloodm Albumin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human Bloodm Albumin Market Drivers
  • 12.2 Human Bloodm Albumin Market Restraints
  • 12.3 Human Bloodm Albumin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Bloodm Albumin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Bloodm Albumin
  • 13.3 Human Bloodm Albumin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Bloodm Albumin Typical Distributors
  • 14.3 Human Bloodm Albumin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Bloodm Albumin. Industry analysis & Market Report on Human Bloodm Albumin is a syndicated market report, published as Global Human Bloodm Albumin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Human Bloodm Albumin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo